Medi Assist changes Dr. Chhatwal’s role to Non-Executive Director
Medi Assist Healthcare Services Ltd changes Dr. Vikram Jit Singh Chhatwal’s designation to Non-Executive, Non-Independent Director effective August 08, 2026, to separate Chairman and executive roles. The move strengthens governance and succession planning, with Dr. Chhatwal ceasing to be Key Managerial Personnel while remaining on the Board.

*this image is generated using AI for illustrative purposes only.
Medi Assist Healthcare Services Ltd has initiated a structural change in its Board leadership by altering the designation of Dr. Vikram Jit Singh Chhatwal from Whole-Time Director to Non-Executive, Non-Independent Director, effective August 08, 2026. This transition, which takes effect at the close of business hours on that date, is designed to separate the roles of Chairman and executive management, thereby strengthening the company’s governance framework and succession planning. Consequently, Dr. Chhatwal will cease to be a Key Managerial Personnel of the company while continuing on the Board as Chairman liable to retire by rotation.
The Board of Directors approved the change based on the recommendation of the Nomination and Remuneration Committee. The decision was formalized during a Board meeting that commenced at 1:45 p.m. (IST) and concluded at 3:00 p.m. (IST) on August 08, 2026. The approval remains subject to the consent of the company’s members and any other regulatory approvals required under applicable laws.
Dr. Chhatwal, who holds DIN 01606329, brings extensive experience to his new role. He holds a Bachelor’s degree in Medicine and Surgery from Jawaharlal Nehru Medical College, a Doctor of Philosophy from the National University of Singapore, a Master’s Degree in Business Administration in International Management from École Nationale des Ponts et Chaussées, Paris, and a Post-Graduate Diploma in Public Health Administration from the Institute of Healthcare Administration, Chennai. Prior to joining Medi Assist, he served as CEO of Reliance Health and CEO of Apollo Health Street, part of the Apollo Hospitals Group.
| Particulars | Details |
|---|---|
| Change in Designation | From Whole-Time Director to Non-Executive, Non-Independent Director |
| Effective Date | August 08, 2026 |
| Key Managerial Status | Ceases to be KMP from August 08, 2026 |
| Regulatory Basis | Regulation 30 of SEBI Listing Regulations |
| Debarment Status | Not debarred from holding office |
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company confirmed that Dr. Chhatwal is not debarred from holding the office of Director pursuant to any SEBI Order or other statutory authority. There are no disclosed relationships between directors regarding this appointment.
Governance Implications
The separation of the Chairman and Chief Executive roles is a key corporate governance best practice aimed at enhancing board independence and oversight. By moving Dr. Chhatwal to a non-executive role, Medi Assist seeks to ensure clearer accountability structures while retaining his strategic guidance as Chairman. The change underscores the company’s commitment to aligning its leadership structure with global governance standards, particularly relevant given Dr. Chhatwal’s background in international healthcare management.
Historical Stock Returns for Medi Assist Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.60% | +2.10% | +0.23% | -9.59% | -33.66% | -21.36% |
Who has been appointed or will be recruited to fill the vacant Whole-Time Director role, and what is their background?
How might the separation of the Chairman and CEO roles impact Medi Assist's strategic decision-making speed and operational agility in the competitive healthcare sector?
What specific governance metrics or KPIs will Medi Assist use to evaluate the effectiveness of this new board structure in the coming fiscal year?


































